In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MIS in Cardiovascular: The Last Best Hope

Executive Summary

Now it is appropriate to ask whether, for product companies in particular, cardiovascular represents the final and full realization of MIS' promise-or another bumpy ride with disappointment the only certain endpoint. Sidebar: Angioplasty and the MISThreat: The advent of MIS resurrects the historic rivalry between interventional cardiology and cardiac surgeons.
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV000381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel